참고문헌 (20)

1. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 Oct;101(4):927-34. 

2. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003 Mar 1;17(5):643-50. 

   상세보기

3. Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016 Mar 24;2:16014. 

4. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders. Gastroenterology 2016:150(6):1393-1407.e5. 

5. Yang J, Deng Y, Chu H, Cong Y, Zhao J, Pohl D, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013 Mar;11(3):262-8. 

6. Johannesson E, Simren M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011 May; 106(5):915-22. 

   상세보기

7. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009 Jan;104(Suppl 1):S1-35. 

8. The Society of Internal Korean Medicine. Irritable Bowel Syndrome Clinical Practice Guideline of Korean Medicine. National Institute for Korean Medicine Development Korean Medicine Innovation Technology Development Project Team; 2022, p. 41. 

9. Hong EK, Lee JI, Park YC, Kwon DI, Sun DC, Kim JY, et al. A Case Report of Irritable Bowel Syndrome Treated with Daechilgitang-gagambang. J Orient Obstetr Gynecol 2007;20(1):268-76. 

10. Kim KT. Two Case Reports of Patients with Diarrhea-predominant Irritable Bowel Syndrome Treated with Jeoreongchajeonja-tang. J Int Korean Med 2019;40(5):948-56. 

11. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med 2013;2(5) :38-43. 

    상세보기

12. Nagata K, Kamano Y, Kamano S, A clinical therapy for abdominal pains by Shakuyakukanzo-to. Pain and Kampo 1992;2:30. 

13. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997 Apr;11(2) :395-402. 

    상세보기

14. Spiegel B, Bolus R, Harris LA, Lucak S, Naliboff B, Esrailian E, et al. Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther 2009;30(11-12):1159-70. 

15. Hughes S, Sibelli A, Everitt HA, Moss-Morris R, Chalder T, Harvey JM, et al. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study. J Med Internet Res 2020 Nov 20;22(11):e18691. 

16. Wang Y, Huang YQ, Zhu SL, Zhang CR, Chen XL, Hou QK, et al. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial. Trials 2020 Nov 3;21(1):908. 

    상세보기

17. Casado-Bedmar M, Keita AV. Potential neuro -immune therapeutic targets in irritable bowel syndrome. Therap Adv Gastroenterol 2020;13: 1756284820910630. 

    상세보기

18. Huang ST, Chen GY, Lo HM, Lin JG, LeeYS, Kuo CD. Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects. The American journal of Chinese medicine 2006;34(01):23-36. 

19. Lu MJ, Yu Z, He Y, Yin Y, Xu B. Electroacupuncture at ST36 modulates gastric motility via vagovagal and sympathetic reflexes in rats. World J Gastroenterol 2019 May 21;25(19):2315-26. 

    상세보기

20. Suganami A, Sakamoto K, Ono T, Watanabe H, Hijioka N, Murakawa M, et al. The inhibitory effect of shakuyakukanzoto on K+ current in H9c2 cells. Fukushima J Med Sci 2014;60(1): 22-30. 

    상세보기

저자의 다른 논문 :

권승원 (74)